Current Status, Goals, and Research Agenda for Outcome Measures Development in Behcet Syndrome: Report from OMERACT 2014

Hatemi G., Ozguler Y., Direskeneli H., Mahr A., Gul A., Levı V., ...More

JOURNAL OF RHEUMATOLOGY, vol.42, pp.2436-2441, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 42
  • Publication Date: 2015
  • Doi Number: 10.3899/jrheum.141147
  • Journal Name: JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2436-2441
  • Keywords: BEHCET SYNDROME, OUTCOME MEASURES, OUTCOMES, CLINICAL-TRIALS, DISEASE, ONSET
  • Istanbul University Affiliated: Yes

Abstract

Objective. There is an unmet need for reliable, validated, and widely accepted outcomes and outcome measures for use in clinical trials in Behcet syndrome (BS). Our report summarizes initial steps taken by the Outcome Measures in Rheumatology (OMERACT) vasculitis working group toward developing a core set of outcome measures for BS according to the OMERACT methodology, including the OMERACT Filter 2.0, and discussions during the first meeting of the BS working group held during OMERACT 12 (2014).